@article{Wang2026, 
author = {Zijing Wang and Xinyu Zhang and Hongmei Yao},
title = {Research progress on the relationship between vitamin K and atherosclerosis},
year = {2026},
journal = {Journal of Nanjing Medical University (Natural Sciences)},
volume = {46},
number = {11},
pages = {1721-1735},
keywords = {vitamin K, atherosclerosis, vascular calcification, vitamin K-dependent protein, matrix Gla protein, vitamin K antagonists},
url = {https://www.sciopen.com/article/10.7655/NYDXBNSN260080},
doi = {10.7655/NYDXBNSN260080},
abstract = {Atherosclerosis (AS), as the core pathological basis of cardiovascular disease (CVD), involves a multifactorial pathogenesis that includes lipid deposition, inflammatory response, endothelial injury, coagulation dysfunction, and vascular calcification (VC). The global burden of CVD continues to rise, with increasing prevalence and mortality rates, making prevention and personalized treatment key research focuses in public health. Vitamin K, a fat-soluble vitamin, primarily exists in two natural forms: phylloquinone (vitamin K1) and menaquinone (vitamin K2). Traditional understanding has concentrated on its role in coagulation regulation, but recent studies have confirmed its involvement in AS development through various pathways, such as modulating the activity of vitamin K-dependent proteins, exerting anti-inflammatory and antioxidant effects, regulating lipid metabolism, and intervening in the phenotypic transformation of vascular smooth muscle cells. This review explores the relationship between vitamin K and atherosclerosis. It summarizes vitamin K classification and its molecular mechanisms regulating atherosclerosis, discusses clinical correlations of vitamin K with the disease, as well as vitamin K effects on postmenopausal women, patients with chronic kidney disease and diabetes, and impacts of vitamin K antagonists. Future research prospects are proposed to provide a comprehensive insight into their correlation.}
}